Our findings of no difference in PSA levels after initial prescriptions of antidiabetic drugs do not support the hypothesis that the use of common antidiabetic medications leads to lower PSA levels that may mask the presence of prostate cancer in men with diabetes. This evidence concerns the gene KLK3 and prostate carcinoma.